Physician profile
Patrick D Jenkins
NPI 1396855623
$1,458.79
in general payments reported to CMS, 2019-2025
18 companies · $336 in 2025
The $336 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $248 · 2022: $333 · 2023: $323 · 2024: $218 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $877.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $330.42 | 2021-2025 | Jardiance |
| Medtronic, INC. | $237.68 | 2023-2025 | Mycarelink, Linq II, Cobalt Dr Mri Surescan |
| Novo Nordisk INC | $184.04 | 2024-2025 | Wegovy, Ozempic |
| Janssen Pharmaceuticals, INC | $119.16 | 2022-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $96.27 | 2023-2024 | Verquvo, Keytruda |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $89.32 | 2021-2022 | |
| Abbott Laboratories | $83.71 | 2022 | |
| Amgen INC. | $80.25 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $33.67 | 2024 | |
| Kiniksa Pharmaceuticals, LTD. | $32.38 | 2022-2023 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $31.89 | 2023 | Inpefa |
| Cvrx, INC. | $29.18 | 2023 | Barostim Neo System |
| Atricure, INC. | $23.92 | 2022 | |
| Boston Scientific Corporation | $22.90 | 2023 | Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $18.83 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $18.73 | 2024 | Arcalyst |
| Kci USA, INC. | $16.04 | 2021 | |
| Lemaitre Vascular, INC. | $10.40 | 2023 | Artegraft Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Jenkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.